loading
Schlusskurs vom Vortag:
$2.025
Offen:
$2.06
24-Stunden-Volumen:
1.58M
Relative Volume:
0.89
Marktkapitalisierung:
$316.75M
Einnahmen:
$288.95M
Nettoeinkommen (Verlust:
$-119.03M
KGV:
-2.4431
EPS:
-0.9005
Netto-Cashflow:
$60.67M
1W Leistung:
-0.90%
1M Leistung:
-20.29%
6M Leistung:
-51.97%
1J Leistung:
-74.04%
1-Tages-Spanne:
Value
$2.025
$2.21
1-Wochen-Bereich:
Value
$1.99
$2.40
52-Wochen-Spanne:
Value
$1.665
$9.95

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name
Firmenname
Maravai Lifesciences Holdings Inc
Name
Telefon
(858) 546-0004
Name
Adresse
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Name
Mitarbeiter
580
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-18
Name
Neueste SEC-Einreichungen
Name
MRVI's Discussions on Twitter

Vergleichen Sie MRVI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MRVI
Maravai Lifesciences Holdings Inc
2.20 292.99M 288.95M -119.03M 60.67M -0.9005
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
366.54 98.88B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.00 58.84B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
438.93 56.12B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
661.83 41.20B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
288.18 35.49B 3.81B -644.79M -669.77M -6.24

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-26 Herabstufung Robert W. Baird Outperform → Neutral
2024-12-19 Eingeleitet Guggenheim Neutral
2024-12-05 Herabstufung Goldman Neutral → Sell
2024-11-14 Eingeleitet Wolfe Research Peer Perform
2024-11-08 Herabstufung William Blair Outperform → Mkt Perform
2024-08-28 Eingeleitet Wells Fargo Overweight
2024-08-13 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-04-10 Eingeleitet Craig Hallum Buy
2023-12-12 Hochstufung BofA Securities Neutral → Buy
2023-08-08 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2023-05-23 Herabstufung Credit Suisse Outperform → Neutral
2023-05-09 Herabstufung Goldman Buy → Neutral
2023-01-05 Herabstufung UBS Buy → Neutral
2022-12-14 Eingeleitet Deutsche Bank Buy
2022-12-07 Eingeleitet RBC Capital Mkts Outperform
2022-11-03 Herabstufung BofA Securities Buy → Neutral
2022-08-25 Eingeleitet Credit Suisse Outperform
2021-08-05 Fortgesetzt Credit Suisse Outperform
2020-12-16 Eingeleitet KeyBanc Capital Markets Overweight
2020-12-15 Eingeleitet BofA Securities Buy
2020-12-15 Eingeleitet Credit Suisse Outperform
2020-12-15 Eingeleitet Goldman Buy
2020-12-15 Eingeleitet Jefferies Buy
2020-12-15 Eingeleitet Robert W. Baird Outperform
2020-12-15 Eingeleitet Stifel Buy
2020-12-15 Eingeleitet William Blair Outperform
2020-12-14 Eingeleitet UBS Buy
Alle ansehen

Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten

pulisher
Aug 08, 2025

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Not Doing Enough For Some Investors As Its Shares Slump 27% - simplywall.st

Aug 08, 2025
pulisher
Aug 08, 2025

Sentiment analysis tools applied to Maravai LifeSciences Holdings Inc.Insider Strategy for High Conviction Picks - Newser

Aug 08, 2025
pulisher
Aug 07, 2025

Stock Traders Buy Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - Defense World

Aug 07, 2025
pulisher
Aug 04, 2025

When is Maravai LifeSciences Holdings Inc. stock expected to show significant growthMaximize returns with strategic stock selection - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

How many analysts rate Maravai LifeSciences Holdings Inc. as a “Buy”Discover stocks with massive upside potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Maravai LifeSciences Holdings Inc. stock attracting strong analyst attentionHigh-yield market plays - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Maravai LifeSciences Holdings Inc. stock overvalued or undervaluedBuild wealth steadily with smart trading - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Maravai LifeSciences Holdings Inc. stock perform well during market downturnsFree Trend-Following Techniques - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Maravai LifeSciences Holdings Inc. compare to its industry peersSkyrocketing profit margins - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Maravai LifeSciences Holdings Inc.Outstanding investment returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Is Maravai LifeSciences Holdings Inc. a growth stock or a value stockCapitalize on fast-moving market trends - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Has Maravai LifeSciences Holdings Inc. found a price floorWatchlist Generator With Real-Time Entry - Newser

Aug 02, 2025
pulisher
Aug 02, 2025

Pattern recognition hints at Maravai LifeSciences Holdings Inc. upsideFree Beginner Friendly Stock Selection Guide - Newser

Aug 02, 2025
pulisher
Aug 01, 2025

Is Maravai LifeSciences Holdings Inc. meeting your algorithmic filter criteriaFree Swing Trading Entry Point Signals - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

Wells Fargo Reiterates a Buy Rating on Maravai LifeSciences Holdings (MRVI) - Insider Monkey

Jul 31, 2025
pulisher
Jul 31, 2025

14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey

Jul 31, 2025
pulisher
Jul 31, 2025

Price momentum metrics for Maravai LifeSciences Holdings Inc. explainedFree Capital Protection Trading Strategies - Newser

Jul 31, 2025
pulisher
Jul 29, 2025

Why Maravai LifeSciences Holdings Inc. stock attracts strong analyst attention - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 23:24:21 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025 - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

Maravai LifeSciences to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 11 - Quiver Quantitative

Jul 28, 2025
pulisher
Jul 28, 2025

Should I hold or sell Maravai LifeSciences Holdings Inc. stock in 2025Breakthrough capital growth - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Maravai LifeSciences Holdings Inc.Get real-time updates on market trends - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Maravai LifeSciences Holdings Inc. stockConsistent triple-digit returns - Jammu Links News

Jul 28, 2025
pulisher
Jul 27, 2025

What is the dividend policy of Maravai LifeSciences Holdings Inc. stockDiscover top stock picks for aggressive growth - Jammu Links News

Jul 27, 2025
pulisher
Jul 25, 2025

What drives Maravai LifeSciences Holdings Inc. stock pricePowerful market insights - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc.MRVI - FinancialContent

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Maravai LifeSciences Holdings Inc. stockGame-changing returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Maravai LifeSciences Holdings Inc. a good long term investmentTremendous portfolio expansion - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Maravai LifeSciences Holdings Inc. stock overhyped or has real potentialRapid market gains - Jammu Links News

Jul 25, 2025
pulisher
Jul 25, 2025

What institutions are buying Maravai LifeSciences Holdings Inc. stock nowFree Trend-Following Techniques - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc.MRVI - Business Wire

Jul 25, 2025
pulisher
Jul 24, 2025

Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI) - Defense World

Jul 24, 2025
pulisher
Jul 22, 2025

Maravai LifeSciences Holdings Inc. Stock Analysis and ForecastMarket-leading growth rates - Jammu Links News

Jul 22, 2025
pulisher
Jul 22, 2025

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Jul 22, 2025

Finanzdaten der Maravai Lifesciences Holdings Inc-Aktie (MRVI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$78.39
price up icon 0.24%
$37.58
price up icon 1.54%
$109.55
price up icon 0.23%
$28.66
price up icon 2.10%
$111.66
price up icon 0.28%
biotechnology ONC
$288.18
price down icon 3.39%
Kapitalisierung:     |  Volumen (24h):